- Mutation Status Drives PARP Inhibitor Investigation and Treatment in mCRPC.
- Wahner A.
- OncLive. 2023 Feb 1.
- Commentary
- Free Full Text
- Germline Testing in Prostate Cancer: Implementation and Disparities of Care.
- Brown LC, Armstrong AJ.
- JCO Oncol Pract. 2023 Jan 31:OP2200804. doi: 10.1200/OP.22.00804. Epub ahead of print.
- PMID: 36720077
- PubMed abstract
- Commentary
- Free Full Text